NZ Inflammatory Bowel Disease Research Review Issue 52

In this review:

Anti-migration, removable stent for CD strictures
Disease pattern and mortality in microscopic colitis
Cost effectiveness of 5-ASA + biologics or tofacitinib for UC
Anti-SARS-CoV-2 antibody responses with infliximab
Safety of tofacitinib in the COVID-19 pandemic
COVID-19 in hospitalised patients with chronic inflammatory diseases
Food as medicine in CD
Diet in IBD and related immune-mediated inflammatory diseases
Physical activity and risk of IBD among older adults
Ustekinumab or vedolizumab in pregnant IBD patients
Educational intervention improves pregnancy-related knowledge and emotional health among women with IBD
Science blog: Regulatory T cell (Treg) transfer for IBD

Please login below to download this issue (PDF)

Subscribe